Corey Clifford

Corey Clifford is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Texas Medical Branch (UTMB), specializing in Maternal-Fetal Medicine. He is board-certified in Obstetrics and Gynecology and Maternal-Fetal Medicine by the American Board of Obstetrics and Gynecology.

• Education: DO from Kansas City University of Medicine and Biosciences (2013); MBA in Healthcare Leadership from Rockhurst University (2013).
• Training: OBGYN residency at TriHealth Hospitals (2013-2017) with teaching and research awards; Obstetrics Hospitalist fellowship (2018) and Maternal-Fetal Medicine fellowship (2021) at University of Texas Health Science Center at Houston.

His research focuses on maternal-fetal health, particularly antenatal drug exposure (e.g., NSAIDs), neonatal hypertension, and stroke during pregnancy. Clinical work and publications emphasize risk factors, outcomes, and evidence-based practices in perinatal care.

Recent publications include: (1) 2023 retrospective study on stroke outcomes during pregnancy; (2) 2018 analysis of NSAID exposure and neonatal hypertension, cited in clinical guidelines. Research aligns with UTMB's Life Span Health strategic pillar.

• Scientific Awards:
  • Residency Excellence in Teaching Award (TriHealth Hospitals, 2013-2014)
  • SMFM Resident Award for Excellence in Obstetrics (2017)
  • SMFM Award of Research Excellence (2021)

He leads the Starling Registry Study (2021-2026), funded by Baxter Healthcare Corporation, focusing on maternal-fetal interventions. His work highlights collaborations in maternal-fetal medicine and translational research.